Skip to Main Content

Paper Details

Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION.
Circ Cardiovasc Interv
0
2022
Cangrelor, Obese, Patients, Platelet, cangrelor, clopidogrel, myocardial infarction, obese, patients, stent thrombosis
Author NameAffiliation
Robert A HarringtonStanford University Medical Center
Renato D LopesDuke Clinical Research Institute
Kenneth W MahaffeyStanford University Medical Center
Deepak L BhattBrigham and Women's Hospital, Harvard Medical School
  • 1 - 4

Datasets

Release 1.2